BIOCHEMICAL SOCIETY TRANSACTIONS from the medium ( 2 h) depressed the second slow phase of the uptake without altering the initial fast phase. Treatment of cells with arsenate (25 mM) for 3 h resulted in a similar, but more pronounced effect. Both conditions did not abolish and even increased the difference in early uptake rates observed between preadipocytes and adipocytes (data not shown). This indicated that the increase in the early fast phase of oleate uptake seen with adipose conversion did not reflect a metabolic change.
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To investigate whether the increase resulted from induction of the cytosolic FABP, temporal correlations between the increase in transport and the appearance of FABP were examined. The increase in oleate uptake was observed at around day 3 following confluence, while mRNA for FABP could not be detected before day 6 (N. A. Abumrad, unpublished work).
These results indicate that differentiating preadipose cells show an increase in FA transport early following confluence at the beginning of adipose conversion. The increase appears to precede induction of the FABP and of the multiple enzymes functioning in FA esterification or in FA mobilization from triacylglycerols. These cells could serve as a valuable model to study regulation of FA uptake.
In summary, our results indicate that rat adipocytes and cultured BFC-1 adipocytes possess a membrane transport system with high affinity for long-chain FA. The transport step could play a role in the storage and mobilization of FA from adipose tissue. The finding that FA transport is increased as BFC-1 preadipocytes convert into adipocytes and acquire the ability to deposit and mobilize lipid further supports this interpretation.
Introdirctiori
Transport of lactic acid out of the cell is of fundamental importance to the majority of cells, especially so under anaerobic conditions when glycolysis is the major source of energy. Some cells, such as erythrocytes, tumour cells and white muscle cells, are largely dependent on glycolysis for their ATP requirements even under aerobic conditions. In contrast, under some circumstances, the liver and heart may transport lactic acid into the cell for gluconeogenesis and oxidation respectively [ 11. The pK, for lactic acid is 3.86, so that concentrations of the undissociated acid at physiological pH are too low to account for the required rates of lactic acid transport across the plasma membrane by free diffusion [ 11. Although such considerations argue for the presence of a lactic acid carrier, definitive proof was only obtained when we were able to show specific inhibition of lactate and pyruvate transport into human erythrocytes by a-cyano-4-hydroxycinnamate and its analogues [2] . Subsequently, we have used these inhibitors to obtain detailed kinetic analysis of lactate and pyruvate transport across the plasma membrane of the erythrocyte [3-51, hepatocyte [5] and cardiac myocyte [6] , and to determine the substrate specificities of the carriers involved. Studies in other laboratories have confirmed the existence of a specific a-cyanocinnamatesensitive monocarboxylic acid carrier in these and other cells such as smooth and striated muscle, placenta, ascites cells Abbreviation used: DIDS, 4,4'-di-isothiocyanostilbene-2,2'-disulphonate.
and the blood-brain barrier (see [ 5-71 for references). In addition, there appear to be Na+-linked mechanisms for lactate and pyruvate transport in kidney brush-border membranes [8] .
The monocurboxylute currier of erythrocytes L-lactate and pyruvate can enter the erythrocyte by three mechanisms: by free diffusion of the undissociated acid, by exchange with bicarbonate or chloride ions o n the inorganic anion exchange transporter (band 3) or on a specific monocarboxylic acid carrier [3, 4, 9, 101. The latter dominates at physiological concentrations of lactate and pyruvate in most species, although it is absent in ox and sheep erythrocytes 19. 111. Erythrocytes from rabbit and rat contain at least 10-fold more carrier than those from human, while those from guinea-pigs have about 25 times the concentration; the kinetic properties in each case are similar 19-I I I. In rat the K, for pyruvate and lactate are about 1 and 3 mM, while in human erythrocytes the respective values are about 1.6 and 8 mM [3-51. The carrier can catalyse net transport of a carboxylate anion with a proton or the exchange of one carboxylate for another, the latter being faster [3, 4, 121 . Net transport is accelerated as the pH on the opposite side of the membrane to the substrate increases with half-maximal effects at about pH 8.3 [ 12, 131. The substrate specificity of the carrier is quite broad and it accepts a variety of shortchain unsubstituted and 2-or 3-substituted monocarboxylates including the ketone bodies B-hydroxybutyrate and acetoacetate as summarized in Table 1 . For lactate the carrier exhibits a strong stereoselectivity for the L-isomer over the Disomer (Table 2 and [ 1 11). When the side-chain of the monocarboxylate increases in size it becomes a poorer substrate and, when greater than C, or aromatic, an effective inhibitor [3, 10, 141 . The ability of the carrier to transport glycolate 
Identifcution of the erythrocyte monocurboxylate currier
We have studied the effects of a-cyanocinnamate analogues on the labelling of membrane proteins in intact rat erythrocytes and ghosts with either ['HI-N-phenylmaleimide or pyridoxal phosphate followed by ['Hlborohydride. In no case were we able to demonstrate specific protection of the labelling of any protein [9]. However, Jennings & AdamsLackey have reported that dihydro-DIDS is able to inhibit lactate transport and label a specific protein in rabbit erythrocytes [ 16, 17) . We have repeated these experiments and extended them to human, rat and guinea-pig erythrocytes [9] . Erythrocytes were labelled with ['Hldihydro-DIDS and membrane proteins separated by SDS/PAGE. Fluorography showed that several proteins other than band 3 were labelled in all species. In agreement with Jennings and coworkers, we found that with rabbit erythrocytes a broad band of 43-60 kDa was labelled; a-cyanod-hydroxycinnamate afforded some protection against this labelling. A similar band was labelled more extensively in guinea-pig ghosts. This would be expected for the lactate carrier which is 2-3 times more active in the guinea-pig erythrocytes. In the rat and human ghosts, no labelled protein of similar molecular mass was detected. Although this was anticipated for human ghosts, where the transport activity is very low, it is surprising in rat ghosts where the activity of the transporter is similar to that found in rabbit erythrocytes. More recently, we have confirmed these observations by using anti-DIDS antibodies, prepared as described by Jentsch et ul. [ 181, to Western blot SDS/PAGE gels of ghost proteins derived from DIDS-labelled erythrocytes (unpublished observations of R. C. Poole) . These results cast doubt on the identification of the 43-60 kDa protein band as the monocarboxylate carrier.
As an alternative approach we have sought to purify transport activity using solubilization of membrane proteins in the neutral detergent decanoyl-N-methylglucamide. We have successfully reconstituted stereoselective carrier activity from rat, rabbit and guinea-pig erythrocytes [7] . No such activity could be reconstituted from bovine ghosts as would be expected since carrier activity is absent in bovine erythrocytes. More recently, we have produced a significant ( > 10-fold) purification of the rat erythrocyte lactate transporter using f.p.1.c. anion exchange (Mono Q) chromatography of the solubilized protein from ghosts stripped of extrinsic proteins by treatment with KI ([9, 191 and unpublished results of R. C. Poole) . To date we have been unable to affect any further purification by chromatography on phenylagarose, organomercurial-agarose, hydroxyapatite and affinity columns based upon wheat germ lectin, conconavalin A, 5-acetamido-4'-isothiocyanostilbene-2,2'-disulphonate and a-cyanocinnamate. However, we have been able to achieve successful solubilization and reconstitution of activity using a variety of different detergents including Triton X-100, 3-[( 3-cholamidopropyl)-dimethylammonio]-1 -propanesulphonate, deoxycholate and octylglucoside. In each case, detergent removal was by gel filtration and dilution, except in the case of Triton where hydrophobic absorption onto Biobeads SM-2 was used [9] .
The monocurboxylute currier of heputocytes utid skeletul muscle cells
We have studied the transport of lactate and pyruvate into the hepatocyte at 0°C under conditions similar to those used for studying the erythrocyte transporter [S]. A very active stereoselective monocarboxylate carrier was detected with similar kinetic properties and specificity to that found in the erythrocyte (see Table 2 ). Like the carrier of erythrocytes it is inhibited by DIDS, organomercurials and quercetin. In addition to carrier-mediated transport, appreciable a-cyano-4-hydroxycinnamate insensitive transport occurs by free diffusion and possibly, at higher lactate concentrations, by an anionic pathway. Investigations using intracellular pH microelectrodes have shown that skeletal muscle also contains a similar transporter to that found in erythrocytes and hepatocytes [20] .
The motiocurboxylute currier of isoluted curdiuc myocyres
Recently, we have studied the transport of pyruvate and lactate into isolated guinea-pig cardiac myocytes [6] . Surprisingly, our experiments have shown that a different transporter is present in this tissue with distinct properties which are summarized in Table 2 . Although the transporter is inhibited by a-cyanocinnamate derivatives and has a K, for L-lactate similar to that for the erythrocyte carrier, the K, for pyruvate is considerably lower (70 p~) and D-lactate is a much better substrate than it is for the erythrocyte carrier. In general, although the substrate specificity of the carrier of cardiac myocytes is similar to that of erythrocytes, the affinity of the carrier is some 10-fold higher (Table 2 ). An exception to this is L-lactate where the K, values for the two carriers are similar. Thus the stereoselectivity of the cardiac myocyte carrier is considerably less than that of the erythrocyte. This lack of stereoselectivity is also observed for the carrier of Ehrlich ascites cells, but in this case the K, for pyruvate is two orders of magnitude higher than that for the cardiac myocytes [2 11. Thus the available kinetic data suggest that there may be a family of closely related monocarboxylate carriers as there is for glucose transport [22] .
The role of the plasma membrane monocurboxylute currier in the control of metabolism Our measurements show that the activity of the transporter in hepatocytes from starved rats is sufficient to allow equilibration of lactate and pyruvate across the plasma membrane even under conditions of rapid metabolism IS]. Indeed measurements of intracellular and extracellular lactate and pyruvate concentrations under physiological conditions confirm this conclusion [23] . Although there are reports which suggest activation of the carrier in starvation and diabetes, they rely on measurement of transport rates at higher temperatures [24-261. Such conditions probably lead to an underestimate of true rates of transport which do not remain linear for sufficient time to make accurate measurements. Direct measurements provide no support for the suggestion that the carrier activity can limit gluconeogenesis [23] .
It is significant that the monocarboxylate carrier of erythrocytes, ascites cells, hepatocytes and myocytes are all proton linked. This is important, since it allows the net loss or gain of lactic acid from the cell, and it is this that is produced by anaerobic glycolysis and used for gluconeogenesis or respiration. Accumulation of lactic acid within muscle leads to cytosolic acidification and inhibitior, of glycolysis and muscle contraction and it has been suggested that a deficiency of the monocarboxylate carrier may account for some cases of unexplained muscle fatigue [ 2 7 ] . Whether it is the carrier or the blood supply that limits the loss o f lactic acid from normal working white muscle is unknown. In the working perfused heart oxidizing lactic acid as the major respiratory substrate the transporter could be operating close to its maximal velocity 161. Under pathological conditions where ischaemia leads to hypoxia and conscquently high rates of lactic acid production, transport of lactic acid out of the cell might limit clearance of lactic acid from the heart and consequent heart failure. However, once again it may well be the decreased blood flow that is the true limiting factor.
The physiological significance of the distinct properties of the monocarboxylate carrier of the heart is unclear. The low K,,, for pyruvate does explain why the efflux of pyruvic acid from the perfused heart cell is much more rapid than that of lactic acid at the same intracellular concentration [ 2 8 ] . Furthermore, the extracellular lactate/pyruvate ratios are sometimes found to be less than the corresponding intracellular ratios [29, 301. It is also of interest that the heart readily takes up and oxidizes lactic acid unlike most tissues 13 1). Indeed, it also possesses a special isoenzyme of lactate dehydrogenase (H,) for this purpose. This isoenzyme is particularly sensitive to inhibition by pyruvate [ 321 and the presence of a carrier with a low K , for pyruvate might protect the cell from such inhibition as could occur if pyruvate were to accumulate. The relatively high affinity of the carrier for acetate, acetoacetate and /3-hydroxybutyrate may well be important since these monocarboxylates are good respiratory substrates for the heart (see [6] . This procedure assumes that both lactate and p-hydroxybutyrate dehydrogenases are in equilibrium and that all four monocarboxylates equilibrate across both the mitochondrial and plasma membranes. The presence of very active monocarboxylate carriers on both the plasma and mitochondria1 membranes supports the latter assumption. However, what has not been emphasized previously is that such equilibration of monocarboxylates across cellular membranes coupled with their transport between tissues in the bloodstream is capable of equilibrating the redox state of many tissues in the body. Thus we are left with the intriguing question, which tissue sets the global cytosolic and mitochondrial NADH/NAD+ ratios and how is this controlled? Since the liver is the dominant metabolic organ of the body, it would seem likely that it plays this role. However, the redox state of the liver is largely determined by its supply of reduced substrates, especially fatty acids or, under some circumstances, ethanol. In the case of fatty acids, regulation of lipolysis in adipose tissue by the glucagon/insulin ratio plays a major part. Thus high glucagon/insulin ratios will promote high cellular NADH/NAD+ ratios throughout the body, even in those tissues that do not oxidize fatty acids themselves. Might this have some significance in the pathology of diabetes mellitus?
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